Publication: Susceptibilidad al virus herpes simple tipo 1: contribución de complejos genéticos polimórficos relacionados con la citotoxicidad celular
Loading...
Files
Official URL
Full text at PDC
Publication Date
2016-07-08
Authors
Advisors (or tutors)
Editors
Journal Title
Journal ISSN
Volume Title
Publisher
Universidad Complutense de Madrid
Citations
Exportar
Abstract
El virus Herpes simple tipo 1 (HSV-1) infecta a la mayoría de los individuos en edades tempranas, manteniéndose en estado latente en sus ganglios sensitivos durante toda la vida. La primoinfección requiere un contacto directo entre la piel o las mucosas dañadas de un individuo no infectado con viriones infectivos liberados en los fluidos corporales de un sujeto infectado. Esta infección primaria suele pasar desapercibida o causar sintomatología típica de una infección viral leve. Sin embargo, en casos excepcionales, puede ser la causa de enfermedades graves y potencialmente letales como la encefalitis herpética, el síndrome séptico por HSV-1, la infección congénita, el eczema herpeticum o la queratitis herpética (Abel et al, 2010; Chase et al, 1987; Frederick et al, 2002; Leung et al, 2013, Liesegang et al, 2001; Whitley et al, 1991). El paso del virus a través de las barreras anatómicas de un individuo no infectado es seguido por la replicación viral en el sitio de la inoculación. A continuación, los viriones entran en las fibras nerviosas sensitivas y son transportados hacía los cuerpos neuronales en los ganglios sensitivos, donde se mantienen en estado latente…
Herpes Simplex virus type 1 (HSV-1) is a wide-spread human pathogen that infects most adults in early life and establishes life-long latent infection in sensitive ganglia. Quiescent HSV-1 can reactivate periodically in response to certain signals (UV-light exposure, fever, stress) and produce recurrent disease, most often at the site of primary infection. The clinical course of HSV-1 infection varies remarkably, from asymptomatic virion excretion to patients with more than one clinically relevant episode monthly. While the most common clinical picture of HSV-1 reactivation is herpes labialis, a minority of the infected individuals can develop life-threatening episodes of herpetic encephalitis, sepsis-like syndrome, eczema herpeticum, herpetic keratitis or congenital disease. Immunosuppressed individuals are prone to these exacerbated or frequent HSV-1 manifestations, but symptomatic reactivations also occur in many otherwise healthy individuals. Susceptibility to clinically relevant HSV-1 reactivation is thought to depend on the virus itself, environmental factors and host genetics. HSV-1 (Herpesviridae family, Alphaherpesvirinae subfamily) is a large (150-200 nm), spherical, DNA enveloped virus, whose genome includes more than eighty genes. HSV-1 gene transcription follows a stepwise sequence, where three major gene groups are distinguished: immediate early (IE), early and late genes. IE genes are transcribed without prior HSV-1 protein synthesis, as their promoters exploit the host cell transcriptional machinery. IE-gene encoded proteins promote the transcription of early genes and a subset of late genes, which conduct virus DNA and structural proteins synthesis in the productive stage of the infection. Though the classical definition of HSV-1 latency implies viral genome retention in neurons without virion production, there is increasing evidence of limited viral transcription and protein synthesis during this quiescent stage...
Herpes Simplex virus type 1 (HSV-1) is a wide-spread human pathogen that infects most adults in early life and establishes life-long latent infection in sensitive ganglia. Quiescent HSV-1 can reactivate periodically in response to certain signals (UV-light exposure, fever, stress) and produce recurrent disease, most often at the site of primary infection. The clinical course of HSV-1 infection varies remarkably, from asymptomatic virion excretion to patients with more than one clinically relevant episode monthly. While the most common clinical picture of HSV-1 reactivation is herpes labialis, a minority of the infected individuals can develop life-threatening episodes of herpetic encephalitis, sepsis-like syndrome, eczema herpeticum, herpetic keratitis or congenital disease. Immunosuppressed individuals are prone to these exacerbated or frequent HSV-1 manifestations, but symptomatic reactivations also occur in many otherwise healthy individuals. Susceptibility to clinically relevant HSV-1 reactivation is thought to depend on the virus itself, environmental factors and host genetics. HSV-1 (Herpesviridae family, Alphaherpesvirinae subfamily) is a large (150-200 nm), spherical, DNA enveloped virus, whose genome includes more than eighty genes. HSV-1 gene transcription follows a stepwise sequence, where three major gene groups are distinguished: immediate early (IE), early and late genes. IE genes are transcribed without prior HSV-1 protein synthesis, as their promoters exploit the host cell transcriptional machinery. IE-gene encoded proteins promote the transcription of early genes and a subset of late genes, which conduct virus DNA and structural proteins synthesis in the productive stage of the infection. Though the classical definition of HSV-1 latency implies viral genome retention in neurons without virion production, there is increasing evidence of limited viral transcription and protein synthesis during this quiescent stage...
Description
Tesis inédita de la Universidad Complutense de Madrid, Facultad de Medicina, Departamento de Microbiología I, leída el 22/10/2015. Tesis formato europeo (compendio de artículos)